Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study

INTRODUCTION: Reducing intraocular pressure (IOP), the only modifiable risk factor for open-angle glaucoma (OAG), is important for the preservation of vision and slowing of disease progression. Preservative-free tafluprost (0.0015%)/timolol (0.5%) fixed combination (PF Taf-T FC) is an approved combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Ejaz, Pavicic-Astalos, Jasna, Ayan, Filis, King, Anthony J., Kinsella, Matthew, Ng, Eugene, Nita, Anca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190000/
https://www.ncbi.nlm.nih.gov/pubmed/33886093
http://dx.doi.org/10.1007/s12325-021-01725-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190000/
https://www.ncbi.nlm.nih.gov/pubmed/33886093
http://dx.doi.org/10.1007/s12325-021-01725-7

Ejemplares similares